FindTrial
Sign In

MDI

DEVICE9 trials

Sponsors

GlaxoSmithKline, Check-Cap Ltd., LMC Diabetes & Endocrinology Ltd., Medtronic Diabetes, Attikon Hospital

Conditions

AsthmaColo-rectal CancerDiabetes Mellitus, Type 1Pulmonary Disease, Chronic ObstructiveType 1 Diabetes

Phase 4

Study of Inhaler Device Attributes Investigating Critical and Overall Errors, Ease of Use, and Preference Between a Number of Inhaler Devices
CompletedNCT02184624
GlaxoSmithKlinePulmonary Disease, Chronic Obstructive
Start: 2014-08-28End: 2015-07-31Updated: 2017-05-23
To Study Device Attributes by Investigating Errors Made in Use, Ease of Use and Preference Among Different Inhalers in Subjects With Asthma
CompletedNCT02195284
GlaxoSmithKlineAsthma
Start: 2014-11-30End: 2015-05-31Updated: 2015-11-23
A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
CompletedNCT03474081
GlaxoSmithKlinePulmonary Disease, Chronic Obstructive
Start: 2018-03-29End: 2019-07-17Updated: 2021-07-15
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
CompletedNCT03478683
GlaxoSmithKlinePulmonary Disease, Chronic Obstructive
Start: 2018-06-25End: 2019-03-14Updated: 2020-10-28
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
CompletedNCT03478696
GlaxoSmithKlinePulmonary Disease, Chronic Obstructive
Start: 2018-06-25End: 2019-03-18Updated: 2020-10-28

Unknown Phase

Motility of the Check-cap's MD1 Colon Capsule in Subjects Following Colon Rectal Cancer Screening by Colonoscopy
CompletedNCT03785665
Check-Cap Ltd.Colo-rectal Cancer
Start: 2019-06-15End: 2022-01-11Updated: 2022-01-19
Canadian Real-World Outcomes of Omnipod Initiation in People With T1D
CompletedNCT04226378
LMC Diabetes & Endocrinology Ltd.Diabetes Mellitus, Type 1
Start: 2020-01-20End: 2020-02-09Updated: 2020-02-21
ADvanced Hybrid Closed Loop Study in Adult Population With Type 1 Diabetes
CompletedNCT04235504
Medtronic DiabetesType 1 Diabetes
Start: 2020-07-13End: 2022-05-30Updated: 2023-03-27
EFFECT OF HYBRID CLOSED-LOOP SYSTEMS ON CARDIOVASCULAR MARKERS IN TYPE 1 DIABETES.
Active, not recruitingNCT07241702
Attikon HospitalType 1 Diabetes
Start: 2019-09-01End: 2025-12-01Target: 100Updated: 2025-11-21

Related Papers

A European Cost–Utility Analysis of the MiniMed™ 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People Living with Type 1 Diabetes
Diabetes Technology & Therapeutics2023-10-0614 citations
Twelve‐month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed‐loop therapy outcomes versus conventional therapy in adults with type 1 diabetes
Diabetes Obesity and Metabolism2023-08-0815 citations
999-P: Cost-Effectiveness of MiniMed 780G Therapy Compared with Multiple Daily Injections (MDI) with Intermittently Scanned Continuous Glucose Monitoring (isCGM) in People with Type 1 Diabetes (T1D)—A United States Perspective
Diabetes2023-06-20
1009-P: Cost-Effectiveness of MiniMed 780G Therapy Compared with Multiple Daily Injections (MDI) with Intermittently Scanned Continuous Glucose Monitoring (isCGM) in People with Type 1 Diabetes (T1D)—A Singapore Perspective
Diabetes2023-06-20
Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study.
2022-09-01114 citations
Randomised controlled trial of Advanced Hybrid Closed Loop in an Adult Population with Type 1 Diabetes (ADAPT): study protocol and rationale
BMJ Open2022-02-016 citations
Peak Inspiratory Flow Rate in COPD: An Analysis of Clinical Trial and Real-World Data.
2021-04-1215 citations
Canadian Real‐World Outcomes of Omnipod Initiation in People with Type 1 Diabetes (COPPER study): Evidence from the LMC Diabetes Registry
Diabetic Medicine2020-10-118 citations
Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials.
2020-05-2930 citations